ArticleMolecular oncology2022

E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models.

Jarle Bruun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.